Aug 23, 2024
Blog Biotechnology Cell Therapy Biomanufacturing: Exploring Global Market Trends with an 11.5% CAGR from 2024 to 2029
Cell therapy biomanufacturing involves the production of cell-based treatments designed to repair, replace, or regenerate damaged tissues and organs. This process includes cultivating, expanding, and modifying cells to create therapies that can treat various diseases, such as cancer, genetic disorders, and autoimmune conditions. The goal is to produce high-quality, effective cell therapies that are safe for patient use while ensuring manufacturing scalability and cost-efficiency.
The cell therapy sector is witnessing rapid growth and innovation, with numerous new therapies advancing through clinical development and gaining regulatory approval. As the demand for cell-based treatments surges, there is an urgent need to optimize biomanufacturing processes to efficiently meet market demands. Advances in biotechnology, automation, and analytics are driving significant improvements in cell therapy manufacturing, offering opportunities to boost productivity, reduce costs, and enhance scalability.
The global market for cell therapy biomanufacturing is set to experience impressive growth. It is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029. This represents a healthy compound annual growth rate (CAGR) of 11.5% from 2024 to 2029. This rapid expansion reflects the increasing interest and investment in cell therapy, signaling a promising future for the industry.
The global market for cell therapy biomanufacturing is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2024 to 2029.
Cellares Corporation: Cellares Corporation is at the forefront of developing automated cell therapy manufacturing platforms. Their innovative Cell Shuttle system is designed to enhance productivity and scalability while reducing costs. This proprietary system enables closed, automated cell processing from cell expansion to final product formulation, significantly streamlining the production of cell therapies.
Allogene Therapeutics: Allogene Therapeutics is a clinical-stage biotechnology company based in the US, focused on developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products. Their innovative approach uses cells from healthy donors to create “off-the-shelf” CAR T therapies, eliminating T cell receptors (TCR) in donor cells to prevent graft-versus-host disease (GvHD). Their pipeline includes treatments for hematological malignancies, solid tumors, and a lymphodepletion agent, aiming to revolutionize cell therapy for cancer and autoimmune diseases.
The cell therapy biomanufacturing market is expected to grow significantly due to technological advancements, increasing funding, and increasing demand for innovative treatments. As the market evolves, stakeholders can expect more efficient manufacturing processes, lower costs, and a wider range of life-saving products.
Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.
Contact us today to find out more.
Kavita Rawat is a Marketing Operations Executive at BCC Research, with a master’s degree in business. She specializes in optimizing marketing strategies and content creation. With her MBA, she combines her passion for marketing with her academic prowess to drive success in the ever-evolving field.
Induced pluripotent stem cells (iPSCs) have emerged as a transformative technolo...
Introduction: Amino acids, the building blocks of life, have evolved from purely...
We are your trusted research partner, providing actionable insights and custom consulting across life sciences, advanced materials, and technology. Allow BCC Research to nurture your smartest business decisions today, tomorrow, and beyond.
Contact UsBCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth opportunities, market sizing, technologies, applications, supply chains and companies with the singular goal of helping you make informed business decisions, free of noise and hype.